Two sides of the table: part II — why IP Australia keeps coming back to the table
21 Oct 2026
Margaret Tregurtha, Acting Director-General of IP Australia, explains why closing the loop with practitioners matters more than any single meeting on its own.In the...
READ MORE
Two sides of the table in Australia: part I — when the profession organised
21 Oct 2026
For ten years, Australian patent attorneys advising software clients faced something close to a coin flip where identical claim strategies...
READ MORE
Bench to bedside: what translational science asks of the IP attorney
12 Oct 2026
Dr Anji Miller of LifeArc explains why protecting a discovery is only ever half the job of getting it to a patient....
READ MORE
G 1/25: Enlarged Board limits compulsory adaptation of the description
Posted by Robert Watson
28 Sep 2026
FICPI welcomes a more proportionate approach, although questions remain over implementation. The EPC does not require formal concordance....
READ MORE
Pharmascience v Janssen (2026 SCC 26): The Supreme Court of Canada, methods of medical treatment and the significance of FICPI’s intervention
Posted by Robert Watson
27 Aug 2026
The case raised fundamental questions about international harmonisation of patent law......
READ MORE
Rethinking patent certainty in the United States
28 Jul 2026
There is a basic tension at the heart of the US patent system that rarely receives sustained attention: patent grants an exclusive right, but...
READ MORE